Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02165358|
Recruitment Status : Completed
First Posted : June 17, 2014
Last Update Posted : November 11, 2016
The purpose of this study is to investigate the paradoxical muscle enlargement in the calves and tongue seen in patients affected by Becker muscular dystrophy and Limb-girdle muscular dystrophy type 2I.
The enlarged calves' muscle quality will be assessed primarily on the basis of the muscle structure on MRI and based on a calculation of muscle strength per cross-sectional area.The findings will be compared with results from non-affected controls.
Additionally we want to describe the tongue muscle appearance on T1-weighted MRI.
|Condition or disease|
|Becker Muscular Dystrophy Limb-Girdle Muscular Dystrophy Type 2I|
The purpose of this study is to investigate the paradoxical muscle enlargement seen in patients affected by Becker muscular dystrophy and Limb-girdle muscular dystrophy type 2I.
Becker and limb-girdle muscular dystrophies are both hereditary muscular disorders. Both diseases appear clinically with shrinkage and muscle weakness of the muscles around the shoulder girdle and pelvis, while muscle hypertrophy of the calves and tongue is seen.
The quality of the enlarged calves has to the investigators knowledge not previously been described, and their hypothesis is that the normal correlation between muscle strength and muscle cross-section is absent in the calf muscles. Thus the investigators hypothesis suggests that there is no actual hypertrophy of the calf muscles, but rather a pseudohypertrofy with reduced force per cross-sectional area. With a picture of increased fat infiltration and disorganized muscle fibers.
The enlarged calves' muscle quality will be assessed primarily on the basis of the muscle structure on MRI (assessed on both T1 imaging, 3-point Dixon scans, and diffusion tension imaging), and based on a calculation of muscle strength per cross-sectional area. Isokinetic muscle dynamometry (Biodex-4) will be used to measure muscle strength. The findings will be compared with results from non-affected controls.
Additionally the investigators want to describe the tongue muscle appearance on T1-weighted MRI.
|Study Type :||Observational|
|Actual Enrollment :||38 participants|
|Observational Model:||Case Control|
|Official Title:||Muscle MRI Study of Patients With Becker Muscular Dystrophy and Limb-girdle Muscular Dystrophy Type 2I|
|Study Start Date :||June 2014|
|Primary Completion Date :||January 2015|
|Study Completion Date :||January 2015|
Patients verified with either becker muscular dystrophy or limb-girdle muscular dystrophy type 2I
Healthy controls matched for age and gender.
- Calves muscle quality [ Time Frame: 1 day ]
the investigators will describe muscle quality by:
MRI scans of the calves comprising of a T1-weighted MRI scan, a 3-point Dixon scan to measure the fraction of fat in the muscle, a short TI inversion recovery (STIR) scan, and a diffusion tensor imaging (DTI) scan to see the muscle fiber organization.
The MRI scans will further be used to measure the fat free muscle cross-sectional area of the muscle groups responsible for plantar flexion and dorsi flexion respectively.
- Biodex muscle strength measurements: Isokinetic muscle dynamometry measurements on plantar flexion and dorsal flexion over the ankle.
- Calculating of muscle strength per muscle cross-sectional area
- MRI T1 scan of the tongue [ Time Frame: 1 day ]MRI T1 scan of the tongue to investigate muscle volume
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02165358
|Neuromuscular Research Unit, Rigshospitalet|
|Copenhagen, Denmark, 2100|
|Principal Investigator:||Nicoline Løkken, Bsc||Neuromuscular Research Unit, Rigshospitalet, Copenhagen|